Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Director departure
Appointed director
|
|
CorMedix Inc. (CRMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Kaplan Myron (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 6,000 shares
@ $4.543, valued at
$27.3k
|
|
| 05/17/2023 |
4
| Costa Paulo F (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 10,000 shares
@ $4.65, valued at
$46.5k
|
|
| 05/17/2023 |
4
| DUNTON ALAN W (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 3,000 shares
@ $4.3266, valued at
$13k
|
|
| 05/17/2023 |
4
| Stewart Robert A (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 10,000 shares
@ $4.3735, valued at
$43.7k
|
|
| 05/17/2023 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 5,000 shares
@ $4.58, valued at
$22.9k
|
|
| 05/12/2023 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Paid exercise price by delivering 37,443 shares
@ $5.3, valued at
$198.4k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2022 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 4,700 shares
@ $3.92, valued at
$18.4k
|
|
| 05/18/2022 |
4
| Kaplan Myron (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 5,000 shares
@ $3.78, valued at
$18.9k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Dillione Janet (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.03, valued at
$80.6k
|
|
| 02/23/2022 |
4
| Costa Paulo F (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.03, valued at
$80.6k
|
|
| 02/23/2022 |
4
| Duncan Gregory Scott (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.03, valued at
$80.6k
|
|
| 02/23/2022 |
4
| DUNTON ALAN W (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.03, valued at
$80.6k
|
|
| 02/23/2022 |
4
| Lefkowitz Steven W (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.03, valued at
$80.6k
|
|
| 02/23/2022 |
4
| Kaplan Myron (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.03, valued at
$80.6k
|
|
| 02/23/2022 |
4
| Nusbickel Thomas (EVP, Chief Commercial Officer) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 100,000 options to buy
@ $4.03, valued at
$403k
|
|
| 02/23/2022 |
4
| Masson-Hurlburt Elizabeth (EVP, Head of Clinical Ops.) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 100,000 options to buy
@ $4.03, valued at
$403k
|
|
| 02/23/2022 |
4
| Mounts Phoebe (General Counsel) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 140,000 options to buy
@ $4.03, valued at
$564.2k
|
|
| 02/23/2022 |
4
| David Matthew T (Interim CEO and CFO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted options to buy
@ $4.03, valued at
$0 |
|
| 12/29/2021 |
4
| Kaplan Myron (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Gifted 20,000 shares
@ $0
Gifted 5,000 shares
@ $0 |
|
|
|
|